Home/Filings/4/0000899243-22-026420
4//SEC Filing

Rajangam Kanya 4

Accession 0000899243-22-026420

CIK 0001854270other

Filed

Jul 19, 8:00 PM ET

Accepted

Jul 20, 6:00 PM ET

Size

5.7 KB

Accession

0000899243-22-026420

Insider Transaction Report

Form 4
Period: 2022-07-18
Rajangam Kanya
Pres. & Chief Med. & Dev. Off.
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-07-18+327,750327,750 total
    Exercise: $1.80Exp: 2032-07-17Common Stock (327,750 underlying)
Footnotes (1)
  • [F1]25% of the shares underlying this option vest on July 5, 2023 and the remainder vest in 36 substantially equal monthly installments thereafter, subject to the reporting person's continued service through the applicable vesting date.

Issuer

Senti Biosciences, Inc.

CIK 0001854270

Entity typeother

Related Parties

1
  • filerCIK 0001816676

Filing Metadata

Form type
4
Filed
Jul 19, 8:00 PM ET
Accepted
Jul 20, 6:00 PM ET
Size
5.7 KB